{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:18:23Z","timestamp":1787019503747,"version":"build-2736575974"},"reference-count":27,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Chemotherapy"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1179\/joc.2005.17.6.593","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T13:05:39Z","timestamp":1389272739000},"page":"593-600","source":"Crossref","is-referenced-by-count":35,"title":["Antimicrobial Spectrum and Potency of Dalbavancin Tested Against Clinical Isolates from Europe and North America (2003): Initial Results from an International Surveillance Protocol"],"prefix":"10.1080","volume":"17","author":[{"given":"R.N.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.R.","family":"Fritsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.S.","family":"Sader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.P.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2013,7,18]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199040030-00007"},{"key":"CIT0002","doi-asserted-by":"crossref","unstructured":"Malabarba A, Goldstein BP. Origin, structure and activity in vitro and in vivo of dalbavancin. J Antimicrob Chemother 2005; 55 (Suppl S2):ii15-ii-20.","DOI":"10.1093\/jac\/dki005"},{"key":"CIT0003","first-page":"179","volume":"44","author":"Candiani G","year":"1999","journal-title":"In vitro and in vivo antibacterial activity of BI397, a new semi-synthetic glycopeptide antibiotic. J Antimicrob Chemother"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.6.1968-1971.2003"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1179\/joc.2001.13.3.244"},{"key":"CIT0006","doi-asserted-by":"crossref","unstructured":"Lopez S, Hackbarth C, Romano G, Trias J, Jabes D, Goldstein BP. In vitro antistaphylococcal activity of dalba-vancin, a novel glycopeptide. J Antimicrob Chemother 2005; 55 (Suppl S2):ii21-ii-24.","DOI":"10.1093\/jac\/dki007"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh401"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.2.770-772.2005"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2004.01051.x"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2003.09.004"},{"key":"CIT0011","doi-asserted-by":"crossref","unstructured":"Buckwalter M, Dowell JA. Population pharmacokinetic analysis of dalbavancin, a novel lipoglycopeptide. J Clin Pharm 2005; (in press).","DOI":"10.1177\/0091270005280378"},{"key":"CIT0012","doi-asserted-by":"crossref","unstructured":"Dorr MB, Jabes D, Cavaleri M, et al. Human pharma-cokinetics and rationale for once-weekly dosing of dalba-vancin, a semi-synthetic glycopeptide. J Antimicrob Chemother 2005; 55 (Suppl S2):ii-25-ii-30.","DOI":"10.1093\/jac\/dki008"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.3.940-945.2004"},{"key":"CIT0014","doi-asserted-by":"crossref","unstructured":"Cavaleri M, Riva S, Valagussa A, et al. Pharmacokinetics and excretion of dalbavancin in the rat. J Antimicrob Chemother 2005; 55 (Suppl S2):ii31-ii35.","DOI":"10.1093\/jac\/dki006"},{"key":"CIT0015","first-page":"1118","volume":"48","author":"Jabes D","year":"2004","journal-title":"Efficacy of dalbavancin against methicillin-resistant Staphylococcus aureus in the rat granuloma pouch infection model. Antimicrob Agents Chemother"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.3.1061-1064.2004"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1086\/427283"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1086\/379015"},{"key":"CIT0019","doi-asserted-by":"crossref","unstructured":"Finch RG, Eliopoulos GM. Safety and efficacy of gly-copeptide antibiotics. J Antimicrob Chemother 2005; 55 (Suppl 52): ii5-ii13.","DOI":"10.1093\/jac\/dki004"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.12.2.117"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa025025"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1086\/423841"},{"key":"CIT0023","volume-title":"100-515. Wayne","author":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Document M","year":"2005"},{"key":"CIT0024","volume-title":"7-A6. Wayne","author":"National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacte-ria that grow aerobically. Document M","year":"2003"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2003.07.008"},{"key":"CIT0026","first-page":"2795","volume":"41","author":"Anderegg TR","year":"2003","journal-title":"Initial quality control evaluations for susceptibility testing of dalbavancin (BI397), an investigational glycopeptide with potent Gram-positive activity. J Clin Microbiol"},{"key":"CIT0027","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1128\/JCM.33.1.24-27.1995","volume":"33","author":"Dutka-Malen S","year":"1995","journal-title":"J Clin Microbiol"}],"container-title":["Journal of Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10256018808623883","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T17:48:42Z","timestamp":1597340922000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1179\/joc.2005.17.6.593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":27,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,7,18]]},"published-print":{"date-parts":[[2005,12]]}},"alternative-id":["10.1179\/joc.2005.17.6.593"],"URL":"https:\/\/doi.org\/10.1179\/joc.2005.17.6.593","relation":{},"ISSN":["1120-009X","1973-9478"],"issn-type":[{"value":"1120-009X","type":"print"},{"value":"1973-9478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}